Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOLUTEGRAVIR Cause Hypersensitivity? 211 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 211 reports of Hypersensitivity have been filed in association with DOLUTEGRAVIR (Juluca). This represents 2.0% of all adverse event reports for DOLUTEGRAVIR.

211
Reports of Hypersensitivity with DOLUTEGRAVIR
2.0%
of all DOLUTEGRAVIR reports
94
Deaths
15
Hospitalizations

How Dangerous Is Hypersensitivity From DOLUTEGRAVIR?

Of the 211 reports, 94 (44.5%) resulted in death, 15 (7.1%) required hospitalization, and 7 (3.3%) were considered life-threatening.

Is Hypersensitivity Listed in the Official Label?

Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for DOLUTEGRAVIR.

What Other Side Effects Does DOLUTEGRAVIR Cause?

Foetal exposure during pregnancy (1,036) Exposure during pregnancy (776) Virologic failure (770) Pathogen resistance (586) Maternal exposure during pregnancy (517) Viral mutation identified (510) Treatment failure (453) Drug ineffective (447) Off label use (413) Blood hiv rna increased (410)

What Other Drugs Cause Hypersensitivity?

ETANERCEPT (10,846) ADALIMUMAB (10,641) METHOTREXATE (9,799) TOCILIZUMAB (9,076) ABATACEPT (8,945) INFLIXIMAB (8,519) RITUXIMAB (8,408) ADAPALENE (8,356) LEFLUNOMIDE (7,926) CERTOLIZUMAB PEGOL (7,353)

Which DOLUTEGRAVIR Alternatives Have Lower Hypersensitivity Risk?

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE DOLUTEGRAVIR vs DOMPERIDONE DOLUTEGRAVIR vs DOMPERIDONE\PANTOPRAZOLE

Related Pages

DOLUTEGRAVIR Full Profile All Hypersensitivity Reports All Drugs Causing Hypersensitivity DOLUTEGRAVIR Demographics